The authors demonstrated that the newly generated epitopes have a strong binding affinity for HLA-A2 and that CD8+ T cells directed against a DRiP epitope are present at significantly higher frequencies in the peripheral blood of people with T1D vs. healthy donors. Here, CD8A is linked to type 1 diabetes mellitus.